Connor, Clark & Lunn Investment Management Ltd.
Position in ILMN — Illumina, Inc.
CIK 1596800
VANCOUVER, A1
Position in ILMN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$24,989,978
-$8,505,138 QoQ
Shares Held
202,742
-20.6% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $206,312,128 across 18 Diagnostics & Research names. ILMN ranks #2 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
134,838 | $64,747,859 | |
| 2 | ILMN |
Illumina, Inc.
This page
|
202,742 | $24,989,978 | |
| 3 | DHR |
Danaher Corp /De/
|
129,426 | $24,539,169 | |
| 4 | GH |
Guardant Health, Inc.
|
254,788 | $23,534,767 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
54,570 | $9,413,325 | |
| 6 | CSTL |
Castle Biosciences Inc
|
377,082 | $9,257,363 | |
| 7 | ADPT |
Adaptive Biotechnologies Corp
|
649,627 | $9,016,822 | |
| 8 | NEO |
Neogenomics Inc
|
938,052 | $6,960,345 |
All Filings in ILMN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,989,978 | 202,742 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $33,495,116 | 255,376 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $12,759,124 | 134,349 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,929,651 | 41,187 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $5,260,797 | 66,307 | Shares | Sole | 2025-05-12 | |
| 2024-09-30 | $16,317,681 | 125,126 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,112,690 | 10,660 | Shares | Sole | 2024-08-09 | |
| 2023-12-31 | $17,704,478 | 130,711 | Shares | Sole | 2024-02-09 | |
| 2023-06-30 | $5,347,295 | 29,319 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $30,160,926 | 133,328 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $21,985,118 | 111,774 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $4,310,406 | 23,225 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,201,730 | 17,853 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $5,871,144 | 17,274 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,685,654 | 7,257 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $12,461,066 | 31,582 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,884,093 | 4,093 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $11,977,963 | 32,061 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,694,737 | 7,487 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,275,406 | 7,568 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,148,606 | 5,964 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $7,037,355 | 26,488 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||